Skip to content

Clinical trials

Phase 2/3 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2/3 Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20043
20052
20082
20093
20103
20112
20126
20132
20144
20151
20162
20174
20182
20194
20212
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated8
Unknown status4
Not yet recruiting2
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation5
Bostal Drug Delivery Co., Ltd2
Manhattan Psychiatric Center2
Mclean Hospital2
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara2
Otsuka Pharmaceutical Co., Ltd.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Shanghai Mental Health Center2
SyneuRx International (Taiwan) Corp2
The University of Hong Kong2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia52
Psychotic Disorders12
Mental Disorders5
Cognitive Dysfunction3
Hallucinations2
Inflammation2
Metabolic Syndrome2
Acute Pain1
Affective Disorders, Psychotic1
Bipolar Disorder1

Trials

Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.